Keywords: pfizer, defends, celebrex, safety, shares, drug, major

Pfizer defends Celebrex safety

Article | 15 November 2004

Print This

Shares in US drug major Pfizer fell after a Canadian newspaper reported that the firm's Celebrex (celecoxib), the best-selling COX-2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in